Back to Search
Start Over
Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic
- Source :
- Hum Vaccin Immunother, Human Vaccines & Immunotherapeutics
- Publication Year :
- 2020
-
Abstract
- A novel coronavirus (2019-nCov) emerged in China, at the end of December 2019 which posed an International Public Health Emergency, and later declared as a global pandemic by the World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) named it SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), while the disease was named COVID-19 (Coronavirus Disease- 2019). Many questions related to the exact mode of transmission, animal origins, and antiviral therapeutics are not clear yet. Nevertheless, it is required to urgently launch a new protocol to evaluate the side effects of unapproved vaccines and antiviral therapeutics to accelerate the clinical application of new drugs. In this review, we highlight the most salient characteristics and recent findings of COVID-19 disease, molecular virology, interspecies mechanisms, and health consequences related to this disease.
- Subjects :
- medicine.medical_specialty
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
Mini Review
030231 tropical medicine
Immunology
Virus Attachment
Disease
medicine.disease_cause
Antiviral Agents
World health
Lopinavir
03 medical and health sciences
0302 clinical medicine
Chiroptera
Pandemic
medicine
Immunology and Allergy
Animals
Humans
030212 general & internal medicine
Intensive care medicine
Coronavirus
Pharmacology
Alanine
Ritonavir
Health consequences
business.industry
SARS-CoV-2
International health
COVID-19
Virus Internalization
Adenosine Monophosphate
COVID-19 Drug Treatment
Coronavirus Protease Inhibitors
Molecular virology
business
Subjects
Details
- ISSN :
- 2164554X
- Volume :
- 17
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Human vaccinesimmunotherapeutics
- Accession number :
- edsair.doi.dedup.....2a4b7ec6b4c44dfa4b2b0b958abd2902